Strategies to increase central N-acetyl aspartylglutamate: A potential treatment for schizophrenia and bipolar disorders [3]

Schizophrenia Research

Volumn 76, Issue 2-3, 2005, Pages 359-360

  Tsai, Shih Jen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DICARBOXYLATE TRANSPORTER; GAMMA GLUTAMYL HYDROLASE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II INHIBITOR; LITHIUM; MAGNESIUM ASPARTATE; METABOTROPIC RECEPTOR 3; N ACETYLASPARTYLGLUTAMIC ACID; UNCLASSIFIED DRUG; ZJ 43;

AGONIST; AMINO ACID BRAIN LEVEL; AMINO ACID SYNTHESIS; BIPOLAR DISORDER; CONCENTRATION (PARAMETERS); ENZYME ACTIVITY; ENZYME INHIBITION; LETTER; MANIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHIZOPHRENIA; SUPPLEMENTATION;

BIPOLAR DISORDER; DIPEPTIDES; HUMANS; NEUROPROTECTIVE AGENTS; SCHIZOPHRENIA;

EID: 20444429762     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.12.018     Document Type: Letter

References (8)

1. G. Chouinard, L. Beauclair, R. Geiser, and P. Etienne A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients Prog. Neuro-Psychopharmacol. Biol. Psychiatry 14 1990 171 180
2. R.F. Deicken, C. Johnson, and M. Pegues Proton magnetic resonance spectroscopy of the human brain in schizophrenia Rev. Neurosci. 11 2000 147 158
3. W. Huang, H. Wang, R. Kekuda, Y.J. Fei, A. Friedrich, J. Wang, S.J. Conway, R.S. Cameron, F.H. Leibach, and V. Ganapathy Transport of N-acetylaspartate by the Na(+)-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain J. Pharmacol. Exp. Ther. 295 2000 392 403
4. R. Kekuda, H. Wang, W. Huang, A.M. Pajor, F.H. Leibach, L.D. Devoe, P.D. Prasad, and V. Ganapathy Primary structure and functional characteristics of a mammalian sodium-coupled high affinity dicarboxylate transporter J. Biol. Chem. 274 1999 3422 3429
5. R.T. Olszewski, N. Bukhari, J. Zhou, A.P. Kozikowski, J.T. Wroblewski, S. Shamimi-Noori, B. Wroblewska, T. Bzdega, S. Vicini, F.B. Barton, and J.H. Neale NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR J. Neurochem. 89 2004 876 885
6. J.C. Soares Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder Int. J. Neuropsychopharmacol. 6 2003 171 180
7. G. Tsai, and J.T. Coyle N-Acetylaspartate in neuropsychiatric disorders Prog. Neurobiol. 46 1995 531 540
8. B. Wroblewska, J.T. Wroblewski, S. Pshenichkin, A. Surin, S.E. Sullivan, and J.H. Neale N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells J. Neurochem. 69 1997 174 181